Highlights SpectraCure AB

Equities

SPEC

SE0007158118

Market Closed - Nasdaq Stockholm Other stock markets 11:29:46 2024-04-29 am EDT			5-day change	1st Jan Change
2.67 ^SEK	-6.97%		+6.59%	-30.83%

Feb. 23	Spectracure AB Continues in the Process of Initiating A Clinical Study, for Primary Localised Prostate Cancer	CI
Feb. 22	SpectraCure AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Spectracure AB Continues in the Process of Initiating A Clinical Study, for Primary Localised Prostate Cancer	Feb. 23	CI
SpectraCure AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 22	CI
SpectraCure AB Conducts a Clinical Study for Patients with Recurrence of Prostate Cancer After Radiotherapy	Dec. 19	CI
SpectraCure AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 16	CI
SpectraCure AB Decides to Seek Approval for Clinical Study of Primary Prostate Cancer	Nov. 16	CI
SpectraCure AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-17	CI
SpectraCure AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-16	CI
SpectraCure AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-22	CI
SpectraCures Signs Letter of Intent with Cheplapharm	22-12-07	CI
SpectraCure AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-17	CI
SpectraCure Receives Patent Approval From EPO For Treatment Systems	22-08-30	MT
European Patent Office Approves Spectracure AB's Patent Application Relating to the Technical Solution in the New Generation of Treatment Systems	22-08-30	CI
SpectraCure AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-26	CI
SpectraCure AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
SpectraCure AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-02-17	CI
SpectraCure AB Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-17	CI
SpectraCure AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-16	CI
SpectraCure AB Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-25	CI
Spectracure AB Publ Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-18	CI
Spectracure AB Provides Update Regarding Clinical Studies for the Treatment of Patients with Recurrent Prostate Cancer	21-03-05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights SpectraCure AB

Equities

SPEC

SE0007158118

Highlights

Filters